Product Information
PRUCALOPRIDE 2 MG TABLET is a generic product labeled by Somerset Therapeutics, LLC, priced at $0.6190 per EA under NDC 70069082201. Its NADAC has been published 54 times since Sep 24, 2025.
FDA first approved this application on Jun 24, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Somerset Therapeutics, LLCNDC
70069082201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PRUCALOPRIDE SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA219078FDA Approved
6/24/2025
TE Code
AB
On Market Since
6/24/2025
Pharmacological Classes
Price Statistics
The NADAC for PRUCALOPRIDE 2 MG TABLET has been published 54 times since Sep 24, 2025, and over the history we have for it it has declined 95.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6190 per EA |
|---|---|
| All-time high | $13.1602 (Oct 15, 2025) |
| All-time low | $0.6190 (Sep 23, 2026) |
| 52-week high | $13.1602 |
| 52-week low | $0.6190 |
| Median price | $0.7045 |
| Average price | $1.6350 |
| Largest weekly change | -94.2% (Oct 22, 2025) |
| Weeks tracked | 54 |
| Tracking since | Sep 24, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Prucalopride succinate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Somerset Therapeutics, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Prucalopride succinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-4 Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PRUCALOPRIDE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PRUCALOPRIDE 2 MG TABLET, manufactured by Somerset Therapeutics, LLC, is $0.6190 per EA (NDC 70069082201), effective Sep 30, 2026.
How has the price of PRUCALOPRIDE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for PRUCALOPRIDE 2 MG TABLET has declined 95.3%. It has been tracked across 54 weekly CMS publications since Sep 24, 2025.
What are the highest and lowest recorded NADAC prices for PRUCALOPRIDE 2 MG TABLET?
Since Sep 24, 2025, the NADAC for PRUCALOPRIDE 2 MG TABLET has ranged from a low of $0.6190 (Sep 23, 2026) to a high of $13.1602 (Oct 15, 2025), with a median of $0.7045 per EA.
Are there cheaper alternatives to PRUCALOPRIDE 2 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of PRUCALOPRIDE 2 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PRUCALOPRIDE 2 MG TABLET?
PRUCALOPRIDE 2 MG TABLET (NDC 70069082201) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.